1. |
Lund LH, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: thirty-second official adult heart transplantation report-2015; focus theme: Early graft failure. J Heart Lung Transplant, 2015, 34(10): 1244.
|
2. |
Pierre AF, Sekine Y, Hutcheon MA, et al. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg, 2002, 123(3): 421-428.
|
3. |
Egan TM, Haithcock JA, Nicotra WA, et al. Ex vivo evaluation of human lungs for transplant suitability. Ann Thorac Surg, 2006, 81(4): 1205-1213.
|
4. |
Ingemansson R, Eyjolfsson A, Mared L, et al. Clinical transplanta-tion of initially rejected donor lungs after reconditioning ex vivo. Ann Thorac Surg, 2009, 87(1): 255-260.
|
5. |
Aigner C, Slama A, Hötzenecker K, et al. Clinical ex vivo lung perfusion-pushing the limits. Am J Transplant, 2012, 12(7): 1839-1847.
|
6. |
Yusen RD. Lung transplantation outcomes: the importance and inadequacies of assessing survival. Am J Transplant, 2009, 9(7): 1493-1494.
|
7. |
Schiavon M, Falcoz PE, Santelmo N, et al. Does the use of extended criteria donors influence early and long-term results of lung transp-lantation? Interact Cardiovasc Thorac Surg, 2012, 14(2): 183-187.
|
8. |
Sommer W, Kühn C, Tudorache I, et al. Extended criteria donor lungs and clinical outcome: results of an alternative allocation algorithm. J Heart Lung Transplant, 2013, 32(11): 1065-1072.
|
9. |
Cypel M, Sato M, Yildirim E, et al. Initial experience with lung donation after cardiocirculatory death in Canada. J Heart Lung Transplant, 2009, 28(8): 753-758.
|
10. |
Levvey BJ, Harkess M, Hopkins P, et al. Excellent clinical outcomes from a national donation‐after‐determination‐of‐cardiac‐death lung transplant collaborative. Am J Transplant, 2012, 12(9): 2406-2413.
|
11. |
de Antonio DG, Marcos R, Laporta R, et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant, 2007, 26(5): 529-534.
|
12. |
Bonser RS, Taylor R, Collett D, et al. Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry. Lancet, 2012, 380(9843): 747-755.
|
13. |
Sabashnikov A, Patil NP, Mohite PN, et al. Influence of donor smoking on midterm outcomes after lung transplantation. Ann Thorac Surg, 2014, 97(3): 1015-1021.
|
14. |
Carrel A, Lindbergh CA. The culture of whole organs. Science, 1935, 81(2112): 621-623.
|
15. |
Steen S, Sjöberg T, Pierre L, et al. Transplantation of lungs from a non-heart-beating donor. Lancet, 2001, 357(9259): 825-829.
|
16. |
Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant, 2008, 27(12): 1319-1325.
|
17. |
Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfu-sion in clinical lung transplantation. N Engl J Med, 2011, 364(15): 1431-1440.
|
18. |
Cypel M, Keshavjee S. Extracorporeal lung perfusion. Curr Opin Organ Transplant, 2011, 16(5): 469-475.
|
19. |
Fischer S, Matte-Martyn A, de Perrot M, et al. Low-potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg, 2001, 121(3): 594-596.
|
20. |
Steen S, Liao Q, Wierup PN, et al. Transplantation of lungs from non–heart-beating donors after functional assessment ex vivo. Ann Thorac Surg, 2003, 76(1): 244-252.
|
21. |
Díez FJM, de Ugarte AV. Ex-vivo perfusion: assessment, recovery and optimisation of human lungs for transplant. Arch Broncone-umol, 2010, 46(5): 213-214.
|
22. |
Oka T, Puskas JD, Mayer E, et al. Low-potassium UW solution for lung preservation: comparison with regular UW, LPD, and Euro-Collins solutions. Transplantation, 1991, 52(6): 984-988.
|
23. |
Inci I, Ampollini L, Arni S, et al. Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant, 2008, 27(11): 1229-1236.
|
24. |
Andrade CF, Martins LK, Tonietto TA, et al. Partial liquid ventila-tion with perfluorodecalin following unilateral canine lung allotran-splantation in non–heart-heating donors. J Heart Lung Transplant, 2004, 23(2): 242-251.
|
25. |
Valenza F, Rosso L, Pizzocri M, et al. The consumption of glucose during ex vivo lung perfusion correlates with lung edema. Trans-plant Proc, 2011, 43(4): 993-996.
|
26. |
Meers CM, Tsagkaropoulos S, Wauters S, et al. A model of ex vivo perfusion of porcine donor lungs injured by gastric aspiration: a step towards pretransplant reconditioning. J Surg Res, 2011, 170(1): 159-167.
|
27. |
Medeiros IL, Pêgo-Fernandes PM, Mariani AW, et al. Histologic and functional evaluation of lungs reconditioned by ex vivo lung perfusion. J Heart Lung Transplant, 2012, 31(3): 305-309.
|
28. |
De Perrot M, Sekine Y, Fischer S, et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplanta-tion. Am J Respir Crit Care Med, 2002, 165(2): 211-215.
|
29. |
Sadaria MR, Smith PD, Fullerton DA, et al. Cytokine expression profile in human lungs undergoing normothermic ex-vivo lung perfusion. Ann Thorac Surg, 2011, 92(2): 478-484.
|
30. |
Ware LB, Wang Y, Fang X, et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet, 2002, 360(9333): 619-620.
|
31. |
Inci I, Zhai W, Arni S, et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J Heart Lung Transplant, 2007, 26(10): 1054-1060.
|
32. |
Inci I, Yamada Y, Hillinger S, et al. Successful lung transplantation after donor lung reconditioning with urokinase in ex vivo lung perfusion system. Ann Thorac Surg, 2014, 98(5): 1837-1838.
|
33. |
Andreasson A, Karamanou DM, Perry JD, et al. The effect of ex vivo lung perfusion on microbial load in human donor lungs. J Heart Lung Transplant, 2014, 33(9): 910-916.
|
34. |
Nakajima D, Cypel M, Bonato R, et al. Ex vivo perfusion treatment of infection in human donor lungs. Am J Transplant, 2016, 16(4): 1229-1237.
|
35. |
Kondo T, Chen F, Ohsumi A, et al. β 2-adrenoreceptor agonist inhalation during ex vivo lung perfusion attenuates lung injury. Ann Thorac Surg, 2015, 100(2): 480-486.
|
36. |
Noda K, Shigemura N, Tanaka Y, et al. Hydrogen preconditioning during ex vivo lung perfusion improves the quality of lung grafts in rats. Transplantation, 2014, 98(5): 499-506.
|
37. |
Harada M, Oto T, Otani S, et al. A neutrophil elastase inhibitor improves lung function during ex vivo lung perfusion. Gen Thorac Cardiovasc Surg, 2015, 18(9): 1-7.
|
38. |
Cypel M, Liu M, Rubacha M, et al. Functional repair of human donor lungs by IL-10 gene therapy. Sci Transl Med, 2009, 1(4): 1-9.
|
39. |
Lee JW, Fang X, Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Nati Acad Sci USA, 2009, 106(38): 16357-16362.
|
40. |
Valenza F, Rosso L, Coppola S, et al. Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation. Transpl Int, 2014, 27(6): 553-561.
|